Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 820 | 1,120 | 2,566 | 0 |
| Cost of Goods | N/A | 636 | 717 | 1,814 | N/A |
| Gross Profit | N/A | 184 | 403 | 752 | N/A |
| Operating Expenses | 2,816 | 2,941 | 2,884 | 3,462 | 2,062 |
| Operating Income | -2,816 | -2,121 | -1,764 | -1,896 | -2,062 |
| Interest Expense | 0 | 0 | 0 | 20 | 0 |
| Other Income | 25 | 93 | 37 | 74 | -6 |
| Pre-tax Income | -2,792 | -2,028 | -1,727 | -1,842 | -2,067 |
| Net Income Continuous | -2,792 | -2,028 | -1,727 | -1,842 | -2,067 |
| Net Income Discontinuous | -175 | N/A | N/A | N/A | -54 |
| Net Income | $-2,966 | $-2,028 | $-1,727 | $-1,788 | $-2,121 |
| EPS Basic Total Ops | -0.73 | -0.51 | -0.44 | -0.07 | -1.94 |
| EPS Basic Continuous Ops | -0.69 | -0.51 | -0.44 | -0.13 | -1.89 |
| EPS Basic Discontinuous Ops | -0.04 | N/A | N/A | N/A | -0.05 |
| EPS Diluted Total Ops | -0.73 | -0.51 | -0.44 | -0.07 | -1.94 |
| EPS Diluted Continuous Ops | -0.69 | -0.51 | -0.44 | -0.13 | -1.89 |
| EPS Diluted Discontinuous Ops | -0.04 | N/A | N/A | N/A | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.51 | -0.44 | N/A | -1.94 |
| EBITDA(a) | $-2,766 | $-2,068 | $-1,711 | $-1,843 | $-2,009 |